Atlas Trials

NF-κB Inhibition in Amyotrophic Lateral Sclerosis

Clinical trial NCT05031351 · UNKNOWN

Trial details

NCT number
NCT05031351
Sponsor
Sunnybrook Health Sciences Centre
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
ALS
Start date
2021-10-19
Primary completion
2022-07-01
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.